store at low temperature
store at -80°C
Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 189.00 | |
5 mg | In stock | $ 476.00 | |
10 mg | In stock | $ 788.00 | |
25 mg | In stock | $ 1,180.00 | |
50 mg | In stock | $ 1,590.00 | |
100 mg | In stock | $ 2,130.00 |
Description | Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers. |
Targets&IC50 | LAN1:5.1 μg/mL |
In vitro |
Naxitamab (Hu3F8; 72 h) exhibits cytotoxicity against the neuroblastoma cell line LAN-1, with an EC50 value of 5.1 μg/mL[1]. Naxitamab (0.1-1 μg/mL; 4 h; peripheral blood mononuclear cells (PBMC) and polymorphonuclear leukocytes (PMN)) demonstrates antibody-dependent cell-mediated cytotoxic effects (ADCC)[1]. |
In vivo | In athymic nude mice with LAN-1 xenografts, Naxitamab (Hu3F8; 100 mg/kg; intravenous; twice a week for 4 weeks) inhibits tumor growth in neuroblastoma xenografts[1]. |
Synonyms | Naxitamab-gqgk, Humanized 3F8, Hu3F8 |
Molecular Weight | N/A |
CAS No. | 1879925-92-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Naxitamab 1879925-92-4 Others Naxitamab-gqgk Humanized 3F8 Hu3F8 inhibitor inhibit